| Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
|---|
| 02/23/2005 | EP1507549A2 Drug therapy for celiac sprue |
| 02/23/2005 | EP1507528A2 Methods for using jnk inhibitors for treating or preventing disease-related wasting |
| 02/23/2005 | EP1507504A1 Cycloalkyl inhibitors of potassium channel function |
| 02/23/2005 | CN1585756A Substituted diphenyl heterocycles useful for treating HCV infection |
| 02/22/2005 | US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 02/17/2005 | WO2005013914A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | WO2004092115A3 Hydroxamates as therapeutic agents |
| 02/17/2005 | WO2003099192A8 Bis-aromatic alkanols |
| 02/17/2005 | US20050038087 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
| 02/17/2005 | US20050038082 Fungicides such as 2-hydroxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-3-phenyl-propionamide; etherification, amidation, sulurization |
| 02/17/2005 | US20050038081 amidation of a heteroary substituted oxoaminobenzoic acid with an amine; for treatment of psoriasis and rheumatoid arthritis using e.g. N-(3-dimethylaminophenyl)-3-(3-methoxybenzamido)-4-methylbenzamide |
| 02/17/2005 | US20050038002 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy |
| 02/17/2005 | US20050037997 Detoxification; hydrolases or esterases; short half-life; non-insulin dependent diabetes; side effect reduction |
| 02/17/2005 | CA2539227A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/16/2005 | EP1506962A2 Nitrogen-containing aromatic heterocycles |
| 02/16/2005 | EP1505968A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes |
| 02/16/2005 | EP1505962A2 Monotherapy for the treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s) |
| 02/15/2005 | US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders |
| 02/10/2005 | WO2005012280A1 Alkynyl aryl carboxamides |
| 02/10/2005 | WO2005012268A1 Sulfonamide derivative having isoxazole ring |
| 02/10/2005 | WO2005012220A2 Cycloalkylidene compounds as modulators of estrogen receptor |
| 02/10/2005 | WO2003099793A9 1,2-azole derivatives with hypoglycemic and hypolipidemic activity |
| 02/10/2005 | US20050033005 Sulfonamide anions as catalysts for NCO oligomerization |
| 02/10/2005 | US20050032852 1-(N-substituted sulfonamido),4-(substituted isooxazoly-4-yl)benzenes, e.g., N-ethyl-4-(5-methyl-3-phenylisoxazol-4-yl)-N-propionylbenzenesulfonamide; side effect reduction; solubility; stability; bioavailability, i.e., readily penetrate membranes; non-steroidal antiinflammatory agents; analgesics |
| 02/10/2005 | US20050032851 E. g.,N-[[4-[2-(5-Methylpyridin-3-yl)-4-(trifluoromethyl)-1H-imidazol-1-yl]phenyl]sulfonyl]acetamide; side effect reduction; non-steroidal antiinflammatory agents; antiarthritic agents; analgesics; antipyretics; acylation of the corresponding sulfoamide by an anhydride a solvent and base |
| 02/10/2005 | US20050032848 Administering enzyme inhibitors of beta secretase, an enzyme responsible for the production of amyloid beta peptide by mediating the cleavage of amyloid precursor proteins; Alzheimer's disease; cognition activators; Down's syndrome; neurodegenerative diseases; other dementias of mixed origins |
| 02/10/2005 | CA2527861A1 Alkynyl aryl carboxamides |
| 02/09/2005 | EP1503986A2 Compositions and methods for treating heart failure |
| 02/09/2005 | EP1503981A2 Substituted tetracycline compounds |
| 02/09/2005 | EP1503755A1 Zonisamide use in obesity and eating disorders |
| 02/09/2005 | EP1150960B1 Polymorphic crystalline forms of celecoxib |
| 02/09/2005 | CN1578775A 3-amido-1, 2-benzoisoxazole derivatives, process for preparation, and use thereof |
| 02/09/2005 | CN1578774A Method for preparing benzenesulfonyl compounds |
| 02/09/2005 | CN1188397C Process for preparation of acid chloride compounds |
| 02/08/2005 | US6852745 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 02/03/2005 | WO2004094384A3 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease |
| 02/03/2005 | WO2004054581A3 Cyclohexyl compounds as ccr5 antagonists |
| 02/03/2005 | US20050027126 Processes for preparing zonisamide intermediates and novel crystalline forms of zonisamide intermediates |
| 02/03/2005 | US20050026978 Isoxazole derivatives and process for producing the same |
| 02/03/2005 | US20050026977 Controlling dosage; sustained and significant weight loss in an overweight subject |
| 02/03/2005 | US20050026908 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer |
| 02/03/2005 | US20050026875 Treating bacterial, viral, or fungal infections, cancer, a lung injury, an eye disorder, neurological disorder or stroke |
| 02/03/2005 | US20050026785 Novel phenyl-propargylether derivatives |
| 02/02/2005 | EP1501787A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 02/02/2005 | EP1501361A1 3-heteroaryl substituted 5-methyloxymethyl isoxazolines used as herbicides |
| 02/02/2005 | EP1330233B1 Method of treating stroke |
| 02/02/2005 | EP1242395B1 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent |
| 02/02/2005 | CN1575279A Substituted thioacetamides |
| 02/02/2005 | CN1575275A Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives |
| 02/02/2005 | CN1187349C 3-(4, 5-dihydroisoxazole-5-yl)-benzoylpyrazole |
| 02/01/2005 | US6849745 Fluorescent dye for use in the detection of preferential compounds |
| 01/27/2005 | WO2005007635A2 Combretastatin derivatives with cytotoxic action |
| 01/27/2005 | WO2005007621A2 Ubiquitin ligase inhibitors |
| 01/27/2005 | WO2005007620A2 New n-hydroxy-4-(3-phenyl-5-methyl-isoxazole-4-yl)-benzenesulfonamide solvates |
| 01/27/2005 | WO2004099197A3 Substituted oxyarenes, and use thereof for controlling pests |
| 01/27/2005 | WO2004064972A3 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 01/27/2005 | US20050020650 For use as as an antagonist against Leukotriene-B-4 receptor, an inhibitor or therapeutic agent for osteoroposis, thus inhibiting osteolysis and stimulating osteogensis; improving its bioavailability by introducing amino acid residue to the amine |
| 01/27/2005 | US20050020634 Acat inhibitors; cardiovascular disorders; restenosis; Alzheimer's disease |
| 01/27/2005 | US20050020540 Biphenylcarboxylic amide derivatives as p38-kinase inhibitors |
| 01/27/2005 | US20050020450 Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives |
| 01/27/2005 | CA2531389A1 Combretastatin derivatives with cytotoxic action |
| 01/27/2005 | CA2530175A1 New n-hydroxy-4-(3-phenyl-5-methyl-isoxazole-4-yl)-benzenesulfonamide solvates |
| 01/26/2005 | EP1499597A2 Compounds and methods for inducing apoptosis in proliferating cells |
| 01/26/2005 | CN1186318C Novel benzenesulphonamide compound, its prepn. process and medicinal compsns. contg. them |
| 01/25/2005 | US6846825 Antibacterial agents |
| 01/25/2005 | CA2231201C Toilet bowl cleaning tablet |
| 01/20/2005 | WO2005005389A2 Malonamide derivatives |
| 01/20/2005 | WO2005004810A2 Arylsulfonamide derivatives |
| 01/20/2005 | US20050014807 Therapeutic compounds for treating dyslipidemic conditions |
| 01/20/2005 | US20050014806 Substituted isoxazoles and their use as antibiotics |
| 01/20/2005 | US20050014787 5-amidino-2-hydroxybenzenesulfonamide derivatives medicinal compoistions containing the same medicinal use thereof and intermediates in the production thereof |
| 01/20/2005 | CA2531485A1 Malonamide derivatives |
| 01/19/2005 | EP1498419A1 Process for preparing alkali metal salts of hydrophobic sulfonamides |
| 01/19/2005 | EP1498418A1 Sulfonamides for treatment of endothelin-mediated disorders |
| 01/19/2005 | EP1497270A1 Amide compounds and methods of using the same |
| 01/19/2005 | EP1497251A1 3-keto or 3-oximoether substituted benzoylcyclohexanediones |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | CN1568185A Compounds effecting glucokinase |
| 01/19/2005 | CN1566096A Prostaglandin agonists and their use to treat bonedisorders |
| 01/19/2005 | CN1185217C Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use |
| 01/13/2005 | WO2004099134A3 Glutaminyl based dp iv-inhibitors |
| 01/13/2005 | US20050009920 Taxol enhancer compounds |
| 01/13/2005 | US20050009900 3-Substituted with a heterocyclic group, e.g., 2-Chloro-5-[1-(2,3-dihydroxy-propyl)-5-methyl-1H-pyrazol-3-yl]-N-(1-hydroxy-cycloheptylmethyl)-benzamide; treatment of IL-1 mediated disorders, including osteo- and rheumatoid arthritis, allergies, asthma, COPD, cancer, and reperfusion or ischemia in stroke |
| 01/13/2005 | US20050009871 Ubiquitin ligase inhibitors |
| 01/12/2005 | EP1495015A1 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers |
| 01/12/2005 | EP1494997A1 Substituted aryl amides |
| 01/12/2005 | EP1494989A2 Compounds that modulate ppar activity and methods for their preparation |
| 01/12/2005 | EP1494669A1 Medicament for preventing and/or treating chronic rejection |
| 01/12/2005 | EP1494666A1 Orally deliverable pharmaceutical composition comprising an active compound having an aminosulfonyl group (cox-2 inhibitor), a polyethylene glycol and a free-radical scavenging antioxidant |
| 01/12/2005 | CN1562985A Method for preparing compound of 5-substitution-3-amido isoxazole |
| 01/11/2005 | US6841683 Using chlorosulfonic acid as well as acetic anhydride and sulfuric acid in an organic solvent |
| 01/11/2005 | US6841682 Prevent binding of adrenergenic receptors |
| 01/11/2005 | US6841519 Isoxazoline derivatives and herbicides containing the same as the active ingredient |
| 01/06/2005 | US20050004232 Acyl sulfonamides as inhibitors of HIV integrase |
| 01/06/2005 | US20050004204 2-Iminopyrrolidine derivatives |
| 01/06/2005 | US20050004197 Thrombin receptors antagonists; oral efficacy |
| 01/06/2005 | US20050004191 Crystallization production of form II; yield, low cost; does not requires rapid cooling |
| 01/06/2005 | US20050004112 C-fms kinase inhibitors |
| 01/05/2005 | EP1493757A1 Photopolymerizable composition |
| 01/05/2005 | EP1492773A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation |